| |
 |
Devises that could revolutionize medical treatment.
 Appeared in Popular Science Magazine.
Z-Medica QuikClot
Many victims survive the accident but bleed to death before
EMTs arrive. That's the inspiration for QuikClot, the first
product outside of the operating room that stops massive
bleeding. Approved by the FDA in May, it consists of a mineral
sponge that rapidly absorbs all but the blood's clotting
factors from an open wound. Troops in Afghanistan have put it
to use, and inventor Frank Hursey plans to release a home
version by early next year.
Self-Tying Sutures
Knotting a suture after a minimally invasive surgery requires
a skilled surgeon—or a smart suture like those demonstrated at
MIT this spring. When exposed to body heat, the biodegradable
shape-memory sutures morph into perfect knots. They could hit
the market in 3 years.
Biological Pacemaker
Pacemakers require risky surgery and don't react to the body's
signals like normal heart cells. This summer, Eduardo Marbán
of Johns Hopkins created the first biological alternative,
which could revolutionize the treatment of heart disease.
Marbán engineered normal guinea pig heart cells to become
pacemaker cells; the results are so promising he hopes to
begin human tests in three years. More than 250,000 Americans
get pacemakers each year.

November 2002.
|
|